Envestnet Portfolio Solutions Inc. Raises Stock Holdings in Balchem Co. (NASDAQ:BCPC)

Envestnet Portfolio Solutions Inc. boosted its stake in Balchem Co. (NASDAQ:BCPC) by 6.4% during the fourth quarter, HoldingsChannel reports. The firm owned 4,402 shares of the basic materials company’s stock after buying an additional 263 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in Balchem were worth $717,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the stock. Natixis Advisors LLC lifted its stake in Balchem by 3.8% during the fourth quarter. Natixis Advisors LLC now owns 22,615 shares of the basic materials company’s stock worth $3,686,000 after purchasing an additional 818 shares during the last quarter. Atala Financial Inc bought a new stake in Balchem in the 4th quarter worth approximately $123,000. Swiss National Bank boosted its stake in Balchem by 0.8% in the fourth quarter. Swiss National Bank now owns 63,800 shares of the basic materials company’s stock worth $10,399,000 after buying an additional 500 shares in the last quarter. Avantax Advisory Services Inc. grew its position in Balchem by 3.0% during the fourth quarter. Avantax Advisory Services Inc. now owns 8,415 shares of the basic materials company’s stock valued at $1,372,000 after acquiring an additional 248 shares during the last quarter. Finally, HighTower Advisors LLC raised its stake in shares of Balchem by 10.0% during the fourth quarter. HighTower Advisors LLC now owns 2,452 shares of the basic materials company’s stock worth $400,000 after acquiring an additional 223 shares in the last quarter. 87.91% of the stock is currently owned by institutional investors.

Balchem Stock Up 2.1 %

Shares of NASDAQ BCPC opened at $164.52 on Tuesday. The firm’s fifty day moving average is $164.88 and its 200 day moving average is $169.34. Balchem Co. has a 52 week low of $137.69 and a 52 week high of $186.03. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19. The company has a market cap of $5.35 billion, a price-to-earnings ratio of 41.86, a PEG ratio of 4.41 and a beta of 0.63.

Balchem (NASDAQ:BCPC) last released its quarterly earnings data on Friday, February 21st. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.11 by ($0.08). The firm had revenue of $240.00 million during the quarter, compared to analysts’ expectations of $239.96 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%. On average, equities research analysts expect that Balchem Co. will post 4.64 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. HC Wainwright reaffirmed a “buy” rating and issued a $190.00 price objective on shares of Balchem in a research note on Monday, February 24th. StockNews.com cut Balchem from a “buy” rating to a “hold” rating in a research note on Tuesday, February 25th. Finally, Sidoti raised Balchem to a “hold” rating in a research note on Tuesday, February 25th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.